Brandon Pallas

Linear Clinical Research provides the most comprehensive clinical trial site capability in Australia, delivered across three specialist facilities, including the purpose-built Joondalup Early Phase Centre and Australia's first private hospital dedicated to cancer and other therapeutic trials, the Advanced Clinical Trial Centre. Leveraging Australia's rapid trial start-up environment and technology investments including eSource, Linear can deliver rapid trials across all phases in healthy volunteers and patient groups, including next generation molecules such as RNA, bi/trispecifics and cell therapy. As a profit-for-purpose company and subsidiary of the Harry Perkins Institute of Medical Research, Linear is solely invested in the success of your clinical program. Our strategic colocation with multiple tertiary hospitals and research institutions guarantees that we possess the essential capabilities required for your specific needs. Having delivered over 500 trials since opening in 2010, Linear has developed a range of innovative practices across volunteer recruitment, data capture, quality assurance and medical governance. We hold dedicated Medical Directors across our Phase I healthy volunteer, oncology and haematology portfolios, each with deep comprehension of the Australian regulatory landscape. This enables Linear to provide critical protocol and design optimisation, eligibility criteria review, and other key medical recommendations. Australia offers a fast regulatory framework to move into human trials without requiring an investigational new drug application. Eligible pre-revenue biotechs also benefit from a generous R&D incentive of 43.5% cashback. Please reach out to learn more about Linear and what the Australian clinical trial sector can offer your programme.